| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1010619845 |
| P356 | DOI | 10.1186/1471-2334-10-135 |
| P8608 | Fatcat ID | release_twulc762dvcbznwmpjxwlhwgaa |
| P932 | PMC publication ID | 2890000 |
| P698 | PubMed publication ID | 20504343 |
| P5875 | ResearchGate publication ID | 44632071 |
| P2093 | author name string | Ioannis Elefsiniotis | |
| Vasilios Raftopoulos | |||
| Eleni Apostolopoulou | |||
| Konstantinos Terzis | |||
| P2860 | cites work | SEROLOGICAL REACTIONS IN PNEUMONIA WITH A NON-PROTEIN SOMATIC FRACTION OF PNEUMOCOCCUS | Q24684141 |
| APACHE II: a severity of disease classification system | Q29547729 | ||
| Changing epidemiology of infections in patients with neutropenia and cancer: emphasis on gram-positive and resistant bacteria | Q33756519 | ||
| 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer | Q34114674 | ||
| Guidelines for the control and prevention of meticillin-resistant Staphylococcus aureus (MRSA) in healthcare facilities | Q34508097 | ||
| Management of infections in the neutropenic patient | Q35640312 | ||
| Catheter-related bloodstream infections in hematology: time for standardized surveillance? | Q36746526 | ||
| Diagnostic and therapeutic approach to persistent or recurrent fevers of unknown origin in adult stem cell transplantation and haematological malignancy | Q40415621 | ||
| Antimicrobial therapy of unexplained fever in neutropenic patients--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO), Study Group Interventional Therapy of Unexplained Fever, Arbeits | Q40550138 | ||
| Surveillance for nosocomial infections and fever of unknown origin among adult hematology-oncology patients | Q40581817 | ||
| Management of infection in cancer patients. studies of the EORTC International Antimicrobial Therapy Group (IATG). | Q40587923 | ||
| Clinical infections and bloodstream isolates associated with fever in patients undergoing chemotherapy for acute myeloid leukemia | Q40610053 | ||
| Empirical and subsequent use of antibacterial agents in the febrile neutropenic patient | Q40657760 | ||
| Bacteraemia in hospitalised patients with malignant blood disorders: a retrospective study of causative agents and their resistance profiles during a 14-year period without antibacterial prophylaxis | Q43580858 | ||
| CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting | Q43758287 | ||
| Trends in bacteraemia on the haematology and oncology units of a UK tertiary referral hospital | Q43874999 | ||
| CANCER resistance surveillance program: initial results from hematology-oncology centers in North America. Chemotherapy Alliance for Neutropenics and the Control of Emerging Resistance | Q44263661 | ||
| Current trends in the epidemiology of nosocomial bloodstream infections in patients with hematological malignancies and solid neoplasms in hospitals in the United States | Q44417864 | ||
| Infection Probability Score (IPS): A method to help assess the probability of infection in critically ill patients | Q44578515 | ||
| Influence of patient age on the frequency of occurrence and antimicrobial resistance patterns of isolates from hematology/oncology patients: report from the Chemotherapy Alliance for Neutropenics and the Control of Emerging Resistance Program (North | Q45996346 | ||
| The changing pattern of infection in neutropenic patients | Q47750416 | ||
| Comparison of infection probability score, APACHE II, and APACHE III scoring systems in predicting need for ventilator and ventilation duration in critically ill patients. | Q48586255 | ||
| The clinical significance of positive blood cultures in the 1990s: a prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults. | Q54568232 | ||
| A prospective evaluation of the Infection Probability Score (IPS) in the intensive care unit | Q64126763 | ||
| Karnofsky performance status revisited: reliability, validity, and guidelines | Q71277291 | ||
| Prognostic factors influencing mortality in cancer patients with neutropenia and bacteremia | Q73073336 | ||
| Criteria for response in patients in clinical trials of empiric antibiotic regimens for febrile neutropenia. Is there agreement? | Q77415804 | ||
| Clinical impact of MRSA in a stem cell transplant unit: analysis before, during and after an MRSA outbreak | Q80034705 | ||
| P304 | page(s) | 135 | |
| P577 | publication date | 2010-05-26 | |
| P1433 | published in | BMC Infectious Diseases | Q15759919 |
| P1476 | title | Infection Probability Score, APACHE II and KARNOFSKY scoring systems as predictors of bloodstream infection onset in hematology-oncology patients | |
| P478 | volume | 10 |
| Q40880244 | Are prognostic scores and biomarkers such as procalcitonin the appropriate prognostic precursors for elderly patients with sepsis in the emergency department? |
| Q36913345 | Bloodstream infections in neutropenic cancer patients: A practical update |
| Q42233832 | Central venous catheter-related infections in hematology and oncology: 2012 updated guidelines on diagnosis, management and prevention by the Infectious Diseases Working Party of the German Society of Hematology and Medical Oncology |
| Q40042111 | Clinical Characteristics of Bloodstream Infections in Pediatric Acute Leukemia: A Single-center Experience with 231 Patients |
| Q39283415 | Current use and potential role of procalcitonin in the diagnostic work up and follow up of febrile neutropenia in hematological patients |
| Q46539691 | Infection Probability Score: A predictor of Clostridium difficile–associated disease onset in patients with haematological malignancy |
| Q64109219 | Management of sepsis in neutropenic cancer patients: 2018 guidelines from the Infectious Diseases Working Party (AGIHO) and Intensive Care Working Party (iCHOP) of the German Society of Hematology and Medical Oncology (DGHO) |
| Q38207933 | Management of sepsis in neutropenic patients: 2014 updated guidelines from the Infectious Diseases Working Party of the German Society of Hematology and Medical Oncology (AGIHO). |
| Q41266125 | Prediction of central venous catheter-related bloodstream infections (CRBSIs) in patients with haematologic malignancies using a modified Infection Probability Score (mIPS). |
| Q39537802 | Predictors of bloodstream infection associated with permanently implantable venous port in solid cancer patients. |
| Q35070651 | Utility of sepsis biomarkers and the infection probability score to discriminate sepsis and systemic inflammatory response syndrome in standard care patients |
Search more.